Valchlor (Mechlorethamine HCl) Patent Expiration, LOE Window & CMS Spending

Valchlor (Mechlorethamine HCl) by Helsinn Birex: FDA Orange Book LOE 2029-07-08, 0 AB generics, $16.5M 2024 CMS Part D & Medicaid spend, and 3 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorHelsinn Birex
FDA Application & PathwayN202317 (NDA)
Exclusivity / Cliff HorizonNear-Term Cliff (2028-2030)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2029-07-08
Orange Book Patents (*PED Extensions)6 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$16.5M
2024 Medicare Part D Spend$13.9M
2024 Medicaid Spend$2.6M
Reported Wholesale Price Change (CA SB 17)3 WAC filings (max 24.5% 2-yr change)